Raymond James Financial Inc Astrazeneca PLC Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Raymond James Financial Inc holds 3,783,251 shares of AZN stock, worth $285 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,783,251
Previous 2,295,589
64.81%
Holding current value
$285 Million
Previous $169 Million
56.69%
% of portfolio
0.09%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
499MCall Options Held
7.24MPut Options Held
2.65M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...